SEC Form 4 · accession 0001209191-19-004241
Tempest Therapeutics, Inc. · TPST
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John P Howe M.D.
Director
Period of report
Jan 15, 2019
Accepted (ET)
Jan 17, 2019 · 4:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001544227
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $8.80 | Jan 15, 2019 | A | 6,000 | A | — | Jan 14, 2029 | Common Stock | 6,000 | 6,000 | D |
Explanation of responses
- F1One hundred percent (100%) of the shares subject to this option will vest on January 15, 2020, subject to the Reporting Person continuing to provide service through such date.